Trevi Therapeutics, Inc. TRVI Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s other income (expense)?
- Trevi Therapeutics, Inc. (TRVI) reported other income (expense) of $1.7M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Trevi Therapeutics, Inc.'s other income (expense) increased by 51.9% year-over-year, from $1.12M to $1.7M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Trevi Therapeutics, Inc.'s other income (expense) has grown at a 44.7% compound annual growth rate (CAGR), from -$1.49M to $6.51M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.